Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
基本信息
- 批准号:9817322
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-17 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAffinityAlternative Complement PathwayAntibodiesAntibody AffinityAntibody FormationAntibody ResponseAntibody titer measurementAntigensAutoimmune ProcessAutoimmunityB Cell ProliferationB-Cell ActivationB-LymphocytesBCL6 geneBiologicalBiologyC3AR1 geneC5a anaphylatoxin receptorCD55 AntigensCell SurvivalCell surfaceCellular biologyChromosomes, Human, Pair 1ComplementComplement 3 ConvertaseComplement 3aComplement 3d ReceptorsComplement 5aComplement ActivationDataDevelopmentDiseaseDown-RegulationEnhancersEventFollicular Dendritic CellsFutureGenerationsGenesGenetic TranscriptionHumoral ImmunitiesImmune responseImmunityImmunizationImmunoglobulin Somatic HypermutationImpairmentInfectionLiftingLigationLightLinkLymphoidMediatingMediator of activation proteinMemory B-LymphocyteModelingMolecularMusOutcomeOutputPathogenicityPhysiologicalPlasma CellsProcessProductionReactionReagentReceptor SignalingRegulationRepressionResearchRoleSignal PathwaySignal TransductionSolidStructureStructure of germinal center of lymph nodeSystemT-LymphocyteTestingTransgenic OrganismsTransplantationVaccineschronic graft versus host diseasecomplement C3d,gcomplement pathwaygene repressiongenetic regulatory proteinin vivoinsightmembernovelorgan transplant rejectionoverexpressionpathogenpreventprogramspromoterreceptorresponserestraint
项目摘要
Project Summary
Humoral immunity crucially protects against pathogens but can function as a pathogenic mediator of multiple
autoimmune and alloimmune disease processes, the latter including chronic graft vs. host disease and
antibody-mediated solid organ transplant rejection. Development of antigen-specific antibody responses
requires T cell-dependent B cell activation and the formation of germinal centers (GC), transient lymphoid
structures where somatic hypermutation and affinity maturation events result in the generation of high affinity,
antibody-producing plasma cells (PC) and memory B cells (Bmem). The physiological signals that control GC
formation and GC B cell fates are incompletely characterized. Our preliminary data identify a previously
unappreciated role for decay accelerating factor (DAF or CD55), a cell surface-expressed complement
regulatory protein, in controlling GC reactions and their resultant output, the production of PC and Bmem. Our
data support the hypothesis that optimal GC function requires downregulation of cell surface expressed DAF
on responding B cells, a process that lifts restraint on local, alternative pathway complement activation and
facilitates C3- and C5-convertase formation and production of C3 and C5 cleavage products. This process
promotes C3a/C3aR1 and C5a/C5aR1 ligations on GC B cells, which would in turn transduce signals
controlling GC B cell proliferation, survival, somatic hypermutation, and/or affinity maturation, and as a
consequence, influence differentiation into memory B cells and/or plasma cells. We will test this paradigm-
shifting hypothesis using unique biological reagents and through 3 interactive aims: 1) To determine the effects
of B cell-expressed DAF, C3aR1 and C5aR1 on T cell-dependent humoral immune responses and distinguish
them from the effects of B cell-expressed CD21. 2) To determine the cellular and molecular mechanisms
through which DAF downregulation and enhanced signaling through C3aR1/C5aR1 in B cells drive affinity
maturation. 3) To determine the molecular basis of DAF downregulation on B cells. This comprehensive
analysis performed by a multi-PI team with expertise in complement biology (Heeger) and B cell biology
(Dominguez-Sola) is likely to provide new insight into fundamental mechanisms of GC dynamics and function.
The results have the potential to guide second order studies aimed at exploiting the complement/B cell axis to
either inhibit development of pathogenic B cell responses (e.g. in transplantation or autoimmunity) or augment
B cell response (e.g. in response to vaccines).
项目概要
体液免疫对于抵御病原体至关重要,但也可以作为多种病原体的致病介质。
自身免疫和同种免疫疾病过程,后者包括慢性移植物抗宿主病和
抗体介导的实体器官移植排斥反应。抗原特异性抗体反应的发展
需要 T 细胞依赖性 B 细胞激活和生发中心 (GC)、瞬时淋巴样的形成
体细胞超突变和亲和力成熟事件导致高亲和力产生的结构,
产生抗体的浆细胞 (PC) 和记忆 B 细胞 (Bmem)。控制GC的生理信号
GC B 细胞的形成和命运尚未完全表征。我们的初步数据确定了先前
衰变加速因子(DAF 或 CD55)(一种细胞表面表达的补体)的作用未被充分认识
调节蛋白,控制 GC 反应及其结果输出、PC 和 Bmem 的产生。我们的
数据支持这样的假设:最佳 GC 功能需要下调细胞表面表达的 DAF
对响应 B 细胞的影响,这是一个解除对局部替代途径补体激活的限制的过程,
促进 C3 和 C5 转化酶的形成以及 C3 和 C5 裂解产物的产生。这个过程
促进 GC B 细胞上的 C3a/C3aR1 和 C5a/C5aR1 连接,从而转导信号
控制 GC B 细胞增殖、存活、体细胞超突变和/或亲和力成熟,并作为
结果,影响分化为记忆 B 细胞和/或浆细胞。我们将测试这个范例 -
使用独特的生物试剂并通过 3 个交互目标改变假设:1) 确定效果
B 细胞表达的 DAF、C3aR1 和 C5aR1 对 T 细胞依赖性体液免疫反应的影响并区分
它们免受 B 细胞表达的 CD21 的影响。 2) 确定细胞和分子机制
DAF 下调并通过 B 细胞中的 C3aR1/C5aR1 增强信号传导驱动亲和力
成熟。 3)确定B细胞上DAF下调的分子基础。这个全面的
由具有补体生物学 (Heeger) 和 B 细胞生物学专业知识的多 PI 团队进行分析
(Dominguez-Sola)可能会为 GC 动力学和功能的基本机制提供新的见解。
该结果有可能指导旨在利用补体/B 细胞轴来
抑制致病性 B 细胞反应的发展(例如移植或自身免疫)或增强
B 细胞反应(例如对疫苗的反应)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Dominguez-Sola其他文献
David Dominguez-Sola的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Dominguez-Sola', 18)}}的其他基金
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10406250 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Decay Accelerating Factor and B cell Immunity
衰变加速因子和 B 细胞免疫
- 批准号:
10623288 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
FOXO1突变在B细胞非霍奇金淋巴瘤发病机制中的作用
- 批准号:
10334435 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas
FOXO1突变在B细胞非霍奇金淋巴瘤发病机制中的作用
- 批准号:
10087895 - 财政年份:2018
- 资助金额:
$ 42.38万 - 项目类别:
ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS
复制应激在 MYC 依赖性淋巴细胞生成过程中的作用
- 批准号:
8146177 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS
复制应激在 MYC 依赖性淋巴细胞生成过程中的作用
- 批准号:
7962386 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
Role of Replication Stress during Myc-dependent Lymphomagenesis
复制应激在 Myc 依赖性淋巴瘤发生过程中的作用
- 批准号:
8785173 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
Role of Replication Stress during Myc-dependent Lymphomagenesis
复制应激在 Myc 依赖性淋巴瘤发生过程中的作用
- 批准号:
8819518 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Continuing Grant